BioCentury | Mar 31, 2020
Finance

With new $450M fund, Gilde is latest European firm to aim for bigger holdings in earlier-stage investments

...he said. The firm held a stake in lung transplant company Breath Therapeutics B.V., which Zambon Co. S.p.A....
BioCentury | Nov 13, 2019
Financial News

As resources diversify, Sofinnova Partners stays course with new €333M fund

...start-up’s takeout by Celgene Corp. (NASDAQ:CELG) in 2017 for $300 million up front; more recently, Zambon Co. S.p.A....
BioCentury | Oct 17, 2019
Financial News

As resources diversify, Sofinnova Partners stays course with new €333M fund

...start-up’s takeout by Celgene Corp. (NASDAQ:CELG) in 2017 for $300 million up front; more recently, Zambon Co. S.p.A....
BioCentury | Sep 16, 2019
Financial News

Sept. 16 Financial Quick Takes: Karyopharm, Mission Bay, Autolus, BenevolentAI, Edigene

...Capital, Eli Lilly and Co. (NYSE:LLY), Mayfield, UC Investments, Wilson Sonsini Goodrich & Rosati and Zambon Co. S.p.A....
BioCentury | Jul 25, 2019
Company News

Breath takeout gives Zambon lung transplant candidate, U.S. foothold

...Italian pharma Zambon is acquiring Sofinnova Partners portfolio company Breath Therapeutics for €140 million ($156 million...
...B.V. (Munich, Germany) are also eligible for up to €360 million ($401 million) in milestones. Zambon Co. S.p.A....
...Seghezzi said. L-CsA-i is in a pair of Phase III trials, with data due 2021; Zambon...
BioCentury | Mar 23, 2017
Clinical News

Xadago regulatory update

...Neither Newron nor US WorldMeds responded to inquires regarding Xadago's launch date or price. Zambon...
...Seika has rights to the drug in Asian territories. Newron Pharmaceuticals S.p.A. (SIX:NWRN), Bresso, Italy Zambon Co. S.p.A....
...Tokyo, Japan Product: Xadago safinamide Business: Neurology Julian Zhu safinamide Xadago Meiji Seika Pharma Co. Ltd. Newron Pharmaceuticals S.p.A. US WorldMeds LLC Zambon Co. S.p.A. Monoamine...
BioCentury | Mar 21, 2017
Company News

FDA approves Newron's Xadago

...Newron nor US WorldMeds responded to inquires regarding Xadago's launch date or price. Newron's partner Zambon Co. S.p.A....
...after Swiss market hours. It lost CHF1.10 to CHF26.60 on Tuesday. Becky Simon Xadago Newron Pharmaceuticals S.p.A. US WorldMeds LLC Zambon Co. S.p.A. Monoamine...
BioCentury | Jan 20, 2017
Company News

Zambon, CSL deal

...rights to develop and commercialize Parkinson’s disease drug Xadago safinamide in Australia and New Zealand. Zambon...
...respond to inquiries. Zambon Co. S.p.A. , Bresso, Italy CSL Ltd. (ASX:CSL), Melbourne, Australia Business: Neurology Alicia Parker safinamide Xadago CSL Ltd. Zambon Co. S.p.A. Monoamine...
BioCentury | Dec 31, 2016
Finance

Delivering takeouts

...Ingrezza valbenazine Tardive dyskinesia FDA panel; PDUFA date 2/16/17; 4/11/17 Newron Pharmaceuticals S.p.A. (SIX:NWRN) / Zambon Co. S.p.A....
BioCentury | Dec 16, 2016
Regulation

Blip or dip?

...Heplisav-B HBV vaccine HBV vaccination Safety Newron Pharmaceuticals S.p.A. (SIX:NWRN) / US WorldMeds LLC / Zambon Co. S.p.A....
Items per page:
1 - 10 of 101
BioCentury | Mar 31, 2020
Finance

With new $450M fund, Gilde is latest European firm to aim for bigger holdings in earlier-stage investments

...he said. The firm held a stake in lung transplant company Breath Therapeutics B.V., which Zambon Co. S.p.A....
BioCentury | Nov 13, 2019
Financial News

As resources diversify, Sofinnova Partners stays course with new €333M fund

...start-up’s takeout by Celgene Corp. (NASDAQ:CELG) in 2017 for $300 million up front; more recently, Zambon Co. S.p.A....
BioCentury | Oct 17, 2019
Financial News

As resources diversify, Sofinnova Partners stays course with new €333M fund

...start-up’s takeout by Celgene Corp. (NASDAQ:CELG) in 2017 for $300 million up front; more recently, Zambon Co. S.p.A....
BioCentury | Sep 16, 2019
Financial News

Sept. 16 Financial Quick Takes: Karyopharm, Mission Bay, Autolus, BenevolentAI, Edigene

...Capital, Eli Lilly and Co. (NYSE:LLY), Mayfield, UC Investments, Wilson Sonsini Goodrich & Rosati and Zambon Co. S.p.A....
BioCentury | Jul 25, 2019
Company News

Breath takeout gives Zambon lung transplant candidate, U.S. foothold

...Italian pharma Zambon is acquiring Sofinnova Partners portfolio company Breath Therapeutics for €140 million ($156 million...
...B.V. (Munich, Germany) are also eligible for up to €360 million ($401 million) in milestones. Zambon Co. S.p.A....
...Seghezzi said. L-CsA-i is in a pair of Phase III trials, with data due 2021; Zambon...
BioCentury | Mar 23, 2017
Clinical News

Xadago regulatory update

...Neither Newron nor US WorldMeds responded to inquires regarding Xadago's launch date or price. Zambon...
...Seika has rights to the drug in Asian territories. Newron Pharmaceuticals S.p.A. (SIX:NWRN), Bresso, Italy Zambon Co. S.p.A....
...Tokyo, Japan Product: Xadago safinamide Business: Neurology Julian Zhu safinamide Xadago Meiji Seika Pharma Co. Ltd. Newron Pharmaceuticals S.p.A. US WorldMeds LLC Zambon Co. S.p.A. Monoamine...
BioCentury | Mar 21, 2017
Company News

FDA approves Newron's Xadago

...Newron nor US WorldMeds responded to inquires regarding Xadago's launch date or price. Newron's partner Zambon Co. S.p.A....
...after Swiss market hours. It lost CHF1.10 to CHF26.60 on Tuesday. Becky Simon Xadago Newron Pharmaceuticals S.p.A. US WorldMeds LLC Zambon Co. S.p.A. Monoamine...
BioCentury | Jan 20, 2017
Company News

Zambon, CSL deal

...rights to develop and commercialize Parkinson’s disease drug Xadago safinamide in Australia and New Zealand. Zambon...
...respond to inquiries. Zambon Co. S.p.A. , Bresso, Italy CSL Ltd. (ASX:CSL), Melbourne, Australia Business: Neurology Alicia Parker safinamide Xadago CSL Ltd. Zambon Co. S.p.A. Monoamine...
BioCentury | Dec 31, 2016
Finance

Delivering takeouts

...Ingrezza valbenazine Tardive dyskinesia FDA panel; PDUFA date 2/16/17; 4/11/17 Newron Pharmaceuticals S.p.A. (SIX:NWRN) / Zambon Co. S.p.A....
BioCentury | Dec 16, 2016
Regulation

Blip or dip?

...Heplisav-B HBV vaccine HBV vaccination Safety Newron Pharmaceuticals S.p.A. (SIX:NWRN) / US WorldMeds LLC / Zambon Co. S.p.A....
Items per page:
1 - 10 of 101